Researcher at Peptide Chemistry Research Institute, K. N. Toosi University of Technology
In recent decades, pharmaceutical companies have increasingly focused on the production and commercialization of 80 FDA-approved therapeutic peptides. Nonetheless, peptide synthesis at both academic and industrial scales has numerous disadvantages, including the utilization of substantial quantities of very toxic coupling chemicals and solvents. SpinChem's RBR technology can improve the solid-phase to liquid ratio, thereby reducing solvent consumption and lowering waste in peptide synthesis.
⬇️Minimizing waste is a crucial step on the journey to sustainable manufacturing. As one of the 12 guiding principles of green chemistry, it should influence our global efforts. This principle is equally important in producing high-quality materials on a small scale, such as pharmaceutical-grade peptides. Discover how this can be accomplished in a review by Mahan Haji Abbasi Somehsaraie, Vaezeh Fathi Vavsari, Mohammad Kamangar and Saeed Balalaie For more details, visit: https://lnkd.in/diGQHTtE We're thrilled that our RBR technology has been recognized for its ability to achieve exceptionally high solid-to-liquid ratios during SPPS, significantly reducing waste through repeated washing steps! #ChemicalWastes #PeptideSynthesis #sustainable #methods #microwave #radiation #SolidPhasePeptideSynthesis
